Top

Reactions Weekly

Published in:

01-06-2022 | COVID-19 Vaccination | Case report

AZD-1222

Symmetrical drug-related intertriginous and flexural exanthema: case report

Published in: Reactions Weekly | Issue 1/2022

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Huang C, et al. Symmetrical drug-related intertriginous and flexural exanthema after AstraZeneca Covid 19 vaccination in a 55-year-old Chinese patient. Australasian Journal of Dermatology 63 (Suppl. 1): 89, May 2022. Available from: URL: http://doi.org/10.1111/ajd.13_13832 [abstract]

Title: AZD-1222
Symmetrical drug-related intertriginous and flexural exanthema: case report
Publication date: 01-06-2022
Publisher: Springer International Publishing
Keywords: COVID-19 Vaccination
Vaccination
Published in: Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-17812-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

AZD-1222

Symmetrical drug-related intertriginous and flexural exanthema: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Tozinameran

Ciprofloxacin/meropenem

Vigabatrin

Enoxaparin sodium

Levofloxacin/vancomycin

Ursodeoxycholic acid